Tradjenta
Tradjenta is linagliptin 5mg film-coated tablets for type 2 diabetes mellitus, a selective DPP-4 inhibitor that spares the incretins.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 5mg | 30 tablets | $89.40 | $2.98 |
| 5mg | 60 tablets | $157.80 | $2.63 |
| 5mg | 90 tablets | $229.50 | $2.55 |
| 5mg | 120 tablets | $290.40 | $2.42 |
| 5mg | 180 tablets | $421.20 | $2.34 |
- Category
- Diabetes Management
- Active ingredient
- Linagliptin
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 5mg
You will receive a quality generic equivalent, depending on stock.
No prescription needed: we place your order for Tradjenta on your behalf.
- Condition
- Type 2 Diabetes Mellitus
- Alternative names
- Trajenta
- Therapeutic class
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
- Pharmacological class
- Gliptin
- Contraindications
- hypersensitivity to linagliptin; type 1 diabetes mellitus; diabetic ketoacidosis
- Minor side effects
- nasopharyngitis; upper respiratory tract infection; headache
- Moderate side effects
- hypoglycaemia
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Originator
- Boehringer Ingelheim
- Onset time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store at room temperature away from moisture and direct light.
- Drug interactions
- rifampicin
- Age restrictions
- Not recommended for children and adolescents under 18 years.
Precautions and warnings
monitor for signs of pancreatitis; observe for skin reactions; avoid in patients with severe hepatic impairment
Serious side effects
acute pancreatitis, requires immediate medical attention; bullous pemphigoid, requires immediate medical attention; anaphylaxis, requires immediate medical attention
Patient summary
Tradjenta is linagliptin 5mg film-coated tablets for type 2 diabetes mellitus, a selective DPP-4 inhibitor that spares the incretins.
Mechanism of action
This medication functions as a selective inhibitor of the DPP-4 enzyme. By preventing the breakdown of incretin hormones, it stimulates insulin secretion and suppresses glucagon release in a glucose-dependent manner, thereby stabilizing blood sugar levels.
Pregnancy and breastfeeding
Pregnancy: Use is not recommended. Breastfeeding: Discuss benefits and risks with a physician.
Tradjenta contains linagliptin, a medication indicated for the management of type 2 diabetes mellitus. The same active ingredient is sold elsewhere under the brand name Trajenta. This medication is supplied as a tablet in 5mg strength to assist with effective glucose regulation.
Buying Tradjenta online
Generic linagliptin remains a more affordable choice than the original brand, offering an accessible solution for expats and those living at a distance from local medical supplies.
What you will receive
Tradjenta is the originator brand name, made by Boehringer Ingelheim. We use it here to identify the medicine only; we are not affiliated with Boehringer Ingelheim and do not ship the original Tradjenta.
- You receive a generic equivalent: the same active ingredient (Linagliptin) at the same dose, mostly recognised branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- Inactive ingredients, tablet appearance and packaging can differ from the original brand; the active ingredient and dose are the same.